Merck EBITDA vs. Shares Owned By Insiders
| MRK Stock | USD 99.18 0.68 0.68% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 6.9 B | Current Value 8.4 B | Quarterly Volatility 5.2 B |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.74 | 0.7317 |
|
| |||||
| Net Profit Margin | 0.0058 | 0.0061 |
|
| |||||
| Operating Profit Margin | 0.0467 | 0.0491 |
|
| |||||
| Pretax Profit Margin | 0.0299 | 0.0314 |
|
| |||||
| Return On Assets | 0.0033 | 0.0034 |
|
| |||||
| Return On Equity | 0.0092 | 0.0097 |
|
|
For Merck profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Merck to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Merck Company utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Merck's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Merck Company over time as well as its relative position and ranking within its peers.
Merck |
Merck's Revenue Breakdown by Earning Segment
Check out Correlation Analysis.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Dividend Share 3.04 | Earnings Share 4.78 | Revenue Per Share 24.931 | Quarterly Revenue Growth 0.044 |
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Merck Company Shares Owned By Insiders vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Merck's current stock value. Our valuation model uses many indicators to compare Merck value to that of its competitors to determine the firm's financial worth. Merck Company is considered to be number one stock in ebitda category among its peers. It is rated below average in shares owned by insiders category among its peers . The ratio of EBITDA to Shares Owned By Insiders for Merck Company is about 115,116,666,667 . At this time, Merck's EBITDA is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Merck by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Merck Shares Owned By Insiders vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Merck |
| = | 6.91 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Merck |
| = | 0.06 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Merck Shares Owned By Insiders Comparison
Merck is currently under evaluation in shares owned by insiders category among its peers.
Merck Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Merck, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Merck will eventually generate negative long term returns. The profitability progress is the general direction of Merck's change in net profit over the period of time. It can combine multiple indicators of Merck, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.2 B | -4.9 B | |
| Operating Income | 3 B | 5.6 B | |
| Income Before Tax | 1.9 B | 1.8 B | |
| Total Other Income Expense Net | -1.1 B | -1 B | |
| Net Income | 365 M | 346.8 M | |
| Income Tax Expense | 1.5 B | 2 B | |
| Net Income Applicable To Common Shares | 16.7 B | 17.5 B | |
| Net Income From Continuing Ops | 4.6 B | 8 B | |
| Non Operating Income Net Other | -1.4 B | -1.3 B | |
| Interest Income | 390 M | 732.6 M | |
| Net Interest Income | -681 M | -715 M | |
| Change To Netincome | 2.3 B | 2.4 B | |
| Net Income Per Share | 0.14 | 0.13 | |
| Income Quality | 35.63 | 37.41 | |
| Net Income Per E B T | 0.19 | 0.18 |
Merck Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Merck. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Merck position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Merck's important profitability drivers and their relationship over time.
Use Merck in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Merck position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will appreciate offsetting losses from the drop in the long position's value.Merck Pair Trading
Merck Company Pair Trading Analysis
The ability to find closely correlated positions to Merck could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck Company to buy it.
The correlation of Merck is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck Company moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Merck can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Merck position
In addition to having Merck in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
To fully project Merck's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Merck Company at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Merck's income statement, its balance sheet, and the statement of cash flows.